Jackson Square Capital, LLC Pfizer Inc Transaction History

Jackson Square Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Mar 05, 2021	SELL	$33.47 - $42.56 $3,012 - $3,830	-90 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$31.75 - $37.25 $17,621 - $20,673	-555 Reduced 86.05%	90 $3,000
Q2 2020 Aug 18, 2020	SELL	$30.12 - $36.54 $21,957 - $26,637	-729 Reduced 53.06%	645 $21,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $59,114 - $84,461	-2,187 Reduced 61.42%	1,374 $45,000
Q4 2019 May 15, 2020	BUY	$32.92 - $37.36 $117,228 - $133,038	3,561 New	3,561 $140,000

3,222

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Capital, LLC with notifications on news.